DUONG CONNIE PM ET AL: "Enhancing the specificity of T-cell cultures for adoptive immunotherapy of cancer", IMMUNOTHERAPY, FUTURE MEDICINE, LONDON, vol. 3, no. 1, 1 January 2011 (2011-01-01) , pages 33-48, XP008175032, ISSN: 1750-7448, DOI: 10.2217/IMT.10.81 (B1)

E. LANITIS ET AL: "Chimeric Antigen Receptor T Cells with Dissociated Signaling Domains Exhibit Focused Antitumor Activity with Reduced Potential for Toxicity In Vivo", CANCER IMMUNOLOGY RESEARCH, vol. 1, no. 1, 7 April 2013 (2013-04-07), pages 43-53, XP055170367, ISSN: 2326-6066, DOI: 10.1158/2326-6066.CIR-13-0008 (B1)

HEGDE M ET AL: "Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma", MOLECULAR THERAPY, NATURE PUBLISHING GROUP, GB, vol. 21, no. 11, 1 November 2013 (2013-11-01), pages 2087-2101, XP002725708, ISSN: 1525-0024, DOI: 10.1038/MT.2013.185 [retrieved on 2013-08-13] (B1)

Haiying Qin ET AL: "Preclinical Development of Bispecific Chimeric Antigen Receptor Targeting Both CD19 and CD22 | Blood Journal", Blood, 1 January 2015 (2015-01-01), page 4427, XP55517725, Retrieved from the Internet: URL:http://www.bloodjournal.org/content/12 6/23/4427?sso-checked=true [retrieved on 2018-10-22] (B1)

JENA BIPULENDU ET AL: "Driving CAR-Based T-Cell Therapy to Success", CURRENT HEMATOLOGIC MALIGNANCY REPORTS, CURRENT SCIENCE INC., PHILADELPHIA, PA, US, vol. 9, no. 1, 2 February 2014 (2014-02-02), pages 50-56, XP035330171, ISSN: 1558-8211, DOI: 10.1007/S11899-013-0197-7 [retrieved on 2014-02-02] (B1)

Qin Haiying; Haso Waleed; Sang Minh Nguyen; Fry Terry J: "4427: Preclinical Development of Bispecific Chimeric Antigen Receptor Targeting Both CD19 and CD22", BLOOD, vol. 126, no. 23, 3 December 2015 (2015-12-03), - 8 December 2015 (2015-12-08), page 4427, XP055274953, US ISSN: 0006-4971 (B1)

WO-A1-2015/075468 (B1)

SCOTT WILKIE ET AL: "Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling", JOURNAL OF CLINICAL IMMUNOLOGY, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 32, no. 5, 17 April 2012 (2012-04-17) , pages 1059-1070, XP035113362, ISSN: 1573-2592, DOI: 10.1007/S10875-012-9689-9 (B1)

SHIVANI SRIVASTAVA ET AL: "Engineering CAR-T cells: Design concepts", TRENDS IN IMMUNOLOGY, vol. 36, no. 8, 1 August 2015 (2015-08-01) , pages 494-502, XP055251965, GB ISSN: 1471-4906, DOI: 10.1016/j.it.2015.06.004 (B1)

Tobias Riët: "Erhöhung der Antigen-Selektivität von T-Zellen durch Koexpression chimärer Antigen- Rezeptoren unterschiedlicher Spezifität Inaugural-Dissertation zur Erlangung des Doktorgrades der Mathematisch-Naturwissenschaftlichen Fakultät der Universität zu Köln vorgelegt von", , 24 November 2010 (2010-11-24), 2010, XP055252275, Retrieved from the Internet: URL:file:///C:/Users/SO51107/AppData/Local /Temp/Dissertation-TobiasRiet-2.pdf [retrieved on 2016-02-22] (B1)

WO-A1-2013/123061 (B1)

WO-A1-2014/065961 (B1)

WO-A1-2014/124143 (B1)

Qin: "Novel CD19/CD22 Bicistronic Chimeric Antigen Receptors Outperform Single or Bivalent Cars in Eradicating CD19+CD22+, CD19-, and CD22- Pre-B Leukemia | Blood Journal", , 7 December 2017 (2017-12-07), XP055492275, Retrieved from the Internet: URL:http://www.bloodjournal.org/content/13 0/Suppl_1/810?sso-checked=true [retrieved on 2018-07-12] (B1)